Capita3 Fund II & IIA portfolio company Claros Technologies announced yesterday the completion of the first successful pilot…
Read the full story here.
We know that women-founded companies demonstrate 35% better returns and 2x more revenue per dollar invested than their male counterparts, yet these entrepreneurs continue to face significant challenges when raising capital…
Read the full story here.
For us, the top 2024 event was the Recast Capital Summit in Sonoma. This was a venture capital emerging manager event set in California’s wine country…
Read the full story here.
In the realm of asset allocation, what role do investments in venture capital funds and emerging managers play? Capita3 had the opportunity to speak with key opinion leaders in institutional asset allocation…
Read the full story here.
We are cautiously optimistic the liquidity market is rebounding. This optimism is balance by the election cycle, which will likely create market volatility but overall we are bullish…
Read the full story here.
The groundbreaking impact of AI and machine learning in advancing healthcare diagnostics is truly remarkable…
Read the full story here.
Claros Technologies, Inc. (ClarosTech™), the leader in PFAS analytical and destruction technologies, announced today that it has raised $22M…
Read the full story here.
Capita3 Funds I, II, and IIA are aimed at the intersection of digital health and deep tech, where hugely underserved sectors relative to their potential are opening up…
Read the full story here.
Portfolio company EmpowerU Inc. was acquired by FullBloom, a leader in early-intervention and evidence-based education and behavioral health solutions that create better life outcomes for children and their families…
Read the full story here.
MDisrupt, the leading expert marketplace for the healthtech industry, is excited to announce the successful completion of a $3 million seed…
Read the full story here.